What are microaneurysms and how do they relate to diabetic retinopathy? Read on to learn more, including why they occur in those with DR.

Oral APX3330 showed clinically meaningful response compared with placebo in slowing progression of diabetic retinopathy in the phase 2 ZETA-1 trial. Ocuphire Pharma’s study results were ...

Diabetic retinopathy (DR) is a progressive complication of diabetes in which retinal vascular damage and abnormalities can lead to vision impairment and blindness. Early diagnosis and management ...

The human studies, published in Prasad, Floyd et al., Circulation Research, compared people with Type 1 diabetes versus controls. The subjects with Type 1 diabetes were further stratified into three ...

Breye Therapeutics has begun dosing in its phase 1b/2a trial of oral danegaptide for treatment of diabetic macular edema, according to a company press release.